Andrew Faughnan | Director of Investor Relations |
John Crowley | Chairman & Chief Executive Officer |
Bradley Campbell | President & Chief Operating Officer |
Daphne Quimi | Chief Financial Officer |
Hung Do | Chief Science Officer |
Jeff Castelli | Chief Portfolio Officer & Head of Gene Therapy |
Anupam Rama | JPMorgan |
Ellie Merle | Cantor Fitzgerald |
Whitney Ijem | Guggenheim |
Ritu Baral | Cowen |
Joseph Schwartz | SVB Leerink |
Mohit Bansal | Citigroup |
Tazeen Ahmad | Bank of America |
Debjit Chattopadhyay | H.C. Wainwright |
Andrea Tan | Goldman Sachs |
Good morning, ladies and gentlemen, and welcome to the Amicus Therapeutics First Quarter 2020 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like to turn the conference over to your host, Mr.